Cybin (CYBN) News Today $8.03 +0.51 (+6.84%) As of 12:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock CYBN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder5 hours ago | businesswire.com3 High-Risk, High-Reward Stocks With Explosive Upside (CYBN)Rezolve, Aurora, and Cybin are 2025's top growth stocks in AI, driverless trucks, and psychedelics, with huge upside potential and key catalysts unfolding.July 16 at 9:46 AM | marketbeat.comCanaccord Genuity Group Lowers Cybin (NYSE:CYBN) Price Target to $70.00July 9, 2025 | americanbankingnews.comCybin (NYSE:CYBN) Price Target Cut to $70.00 by Analysts at Canaccord Genuity GroupJuly 8, 2025 | marketbeat.comHC Wainwright Predicts Cybin's FY2030 Earnings (NYSE:CYBN)July 4, 2025 | marketbeat.comCybin (NYSE:CYBN) Shares Down 18% - Here's WhyJuly 3, 2025 | marketbeat.comCYBN - Cybin Inc Ordinary Shares Ownership - MorningstarJuly 2, 2025 | morningstar.comMREPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible DebenturesJuly 1, 2025 | businesswire.comCybin Reports Fiscal Year 2025 Financial Results and Recent Business HighlightsJune 30, 2025 | businesswire.comCybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible DebenturesJune 30, 2025 | businesswire.comCYBN - Cybin Inc Ordinary Shares Executives - MorningstarJune 27, 2025 | morningstar.comMCybin Inc. (CYBN.NE) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comCybin Granted Key Patent for CYB004 DMT Program, Supports GAD Treatment DevelopmentJune 25, 2025 | msn.comCybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic TherapeuticsJune 13, 2025 | businesswire.comCybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives ConferenceJune 12, 2025 | businesswire.comCantor Fitzgerald Predicts Cybin FY2026 EarningsJune 11, 2025 | marketbeat.comCybin (NYSE:CYBN) Trading Down 5.1% - Should You Sell?June 10, 2025 | marketbeat.comCybin to Participate in Water Tower Research Fireside Chat on May 29, 2025May 22, 2025 | businesswire.comPoint72 Asset Management L.P. Purchases New Position in Cybin Inc. (NYSE:CYBN)May 21, 2025 | marketbeat.comTang Capital Management LLC Increases Stock Holdings in Cybin Inc. (NYSE:CYBN)May 20, 2025 | marketbeat.comSphera Funds Management LTD. Reduces Position in Cybin Inc. (NYSE:CYBN)May 18, 2025 | marketbeat.comCybin (NYSE:CYBN) Upgraded by Cantor Fitzgerald to Strong-Buy RatingMay 17, 2025 | marketbeat.comCybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive DisorderMay 15, 2025 | businesswire.comCybin secures new patent for depression treatment drugMay 9, 2025 | investing.com734,393 Shares in Cybin Inc. (NYSE:CYBN) Acquired by Acorn Capital Advisors LLCMay 4, 2025 | marketbeat.comCybin (NYSE:CYBN) Trading Up 2.9% - Here's What HappenedApril 27, 2025 | marketbeat.comCybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003April 23, 2025 | businesswire.comKnott David M Jr Acquires New Position in Cybin Inc. (NYSE:CYBN)April 2, 2025 | marketbeat.comRosalind Advisors Inc. Has $7.15 Million Position in Cybin Inc. (NYSE:CYBN)March 23, 2025 | marketbeat.comPDS Planning Inc Lowers Stock Holdings in Cybin Inc. (NYSE:CYBN)March 21, 2025 | marketbeat.comCybin (NYSE:CYBN) Earns Buy Rating from Analysts at GuggenheimMarch 14, 2025 | marketbeat.comCybin initiated with a Buy at GuggenheimMarch 12, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cybin (CYBN) and Corbus Pharmaceuticals (CRBP)February 18, 2025 | markets.businessinsider.comHC Wainwright Cuts Cybin (NYSE:CYBN) Price Target to $150.00February 13, 2025 | marketbeat.comCybin (NYSE:CYBN) Given New $73.00 Price Target at Canaccord Genuity GroupFebruary 12, 2025 | marketbeat.comCybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business HighlightsFebruary 10, 2025 | businesswire.comEquities Analysts Set Expectations for Cybin Q3 EarningsJanuary 30, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Cybin FY2029 Earnings?January 30, 2025 | marketbeat.comHC Wainwright Has Negative Outlook of Cybin FY2029 EarningsJanuary 29, 2025 | marketbeat.comCybin’s depression program advancing in Phase 3, says H.C. WainwrightJanuary 28, 2025 | markets.businessinsider.comCybin’s Promising Clinical Developments and Strategic Partnerships Fuel Buy Rating and $190 Price TargetJanuary 28, 2025 | markets.businessinsider.comH.C. Wainwright maintains $190 target on Cybin Inc. sharesJanuary 28, 2025 | msn.comCybin (NYSE:CYBN) Receives "Buy" Rating from HC WainwrightJanuary 27, 2025 | marketbeat.comCybin launches clinical site partnerships to support PARADIGM programJanuary 16, 2025 | markets.businessinsider.comCybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive DisorderJanuary 15, 2025 | businesswire.comCybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025January 13, 2025 | businesswire.comJane Street Group LLC Has $204,000 Stake in Cybin Inc. (NYSE:CYBN)January 13, 2025 | marketbeat.comCybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025January 9, 2025 | businesswire.comCybin (NYSE:CYBN) Trading Up 1% - Time to Buy?December 28, 2024 | marketbeat.comPEAK6 Investments LLC Trims Stock Holdings in Cybin Inc. (NYSE:CYBN)December 6, 2024 | marketbeat.com Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address CYBN Media Mentions By Week CYBN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYBN News Sentiment▼0.520.96▲Average Medical News Sentiment CYBN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYBN Articles This Week▼11▲CYBN Articles Average Week Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies REPL News Today PHAR News Today SANA News Today NUVB News Today AVBP News Today TRVI News Today ANAB News Today IMTX News Today DAWN News Today MRVI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CYBN) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cybin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cybin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
